Search Results - "Loeschmann, Nadine"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
  2. 2

    Aurora kinases as targets in drug-resistant neuroblastoma cells by Michaelis, Martin, Selt, Florian, Rothweiler, Florian, Löschmann, Nadine, Nüsse, Benedikt, Dirks, Wilhelm G, Zehner, Richard, Cinatl, Jr, Jindrich

    Published in PloS one (30-09-2014)
    “…Aurora kinase inhibitors displayed activity in pre-clinical neuroblastoma models. Here, we studied the effects of the pan-aurora kinase inhibitor tozasertib…”
    Get full text
    Journal Article
  3. 3

    multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replication by Michaelis, Martin, Paulus, Christina, Löschmann, Nadine, Dauth, Stephanie, Stange, Elisabeth, Doerr, Hans Wilhelm, Nevels, Michael, Cinatl, Jindrich Jr

    “…Human cytomegalovirus (HCMV) is a major pathogen in immunocompromised individuals. Here, non-toxic concentrations of the anti-cancer kinase inhibitor sorafenib…”
    Get full text
    Journal Article
  4. 4

    Enzastaurin inhibits ABCB1-mediated drug efflux independently of effects on protein kinase C signalling and the cellular p53 status by Michaelis, Martin, Rothweiler, Florian, Löschmann, Nadine, Sharifi, Mohsen, Ghafourian, Taravat, Cinatl, Jr, Jindrich

    Published in Oncotarget (10-07-2015)
    “…The PKCβ inhibitor enzastaurin was tested in parental neuroblastoma and rhabdomyosarcoma cell lines, their vincristine-resistant sub-lines, primary…”
    Get full text
    Journal Article
  5. 5

    ABCB1 as predominant resistance mechanism in cells with acquired SNS-032 resistance by Löschmann, Nadine, Michaelis, Martin, Rothweiler, Florian, Voges, Yvonne, Balónová, Barbora, Blight, Barry A, Cinatl, Jr, Jindrich

    Published in Oncotarget (06-09-2016)
    “…The CDK inhibitor SNS-032 had previously exerted promising anti-neuroblastoma activity via CDK7 and 9 inhibition. ABCB1 expression was identified as major…”
    Get full text
    Journal Article
  6. 6

    The anti-tumoral drug enzastaurin inhibits natural killer cell cytotoxicity via activation of glycogen synthase kinase-3β by Ogbomo, Henry, Biru, Tsigereda, Michaelis, Martin, Loeschmann, Nadine, Doerr, Hans Wilhelm, Cinatl, Jindrich

    Published in Biochemical pharmacology (15-01-2011)
    “…Enzastaurin is a selective protein kinase Cβ inhibitor which is shown to have direct antitumor effect as well as suppress glycogen synthase kinase-3β (GSK-3β)…”
    Get full text
    Journal Article
  7. 7